Overall, the authors’ analysis of the data showed no significant benefit from omega 3 for maintaining remission.
However, 3 studies using enteric-coated capsules reported positive effects, while one that used ordinary gelatin capsules showed no advantage.
The total number of patients enrolled in these studies was small.
No significant adverse events were recorded.
The bottom line?
The authors concluded, “Omega 3 fatty acids are safe and may be effective for maintenance of remission in Crohn’s disease when used in enteric coated capsules. However, there are not sufficient data to recommend the routine use of omega 3 for maintenance of remission in Crohn’s disease.”
For more information, the Ecology Health Center has published a table that summarizes 6 studies.
John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.